Axcelead, Inc.

Private

TokyoHealthcare & Life Scienceshttps://www.axcelead.com/

Last Round

Spinoff

Apr 1, 2019

Company Overview

Axcelead, Inc. is a healthcare platform company that provides integrated drug discovery and development solutions through its subsidiaries, including Axcelead Drug Discovery Partners, Inc.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Application

Keywords

contract research organizationCROdrug discoverynon-clinical safety assessmentADME studiespharmacokineticsdrug discovery informaticsassay developmenttarget validationbiotech R&Doutsourced drug discoveryAI-augmented drug discoverytoxicology servicespharma R&D serviceslab-as-a-service

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Axcelead, Inc. Comparables

Compare Axcelead, Inc. with similar companies based on industry and business-model similarity.

Axcelead, Inc. comparables — related companies by embedding similarity
Company	Similarity	Market Cap
Evotec	81%
Selvita	81%
Shin Nippon Biomedical Laboratories Ltd	80%

View all Comparables

Axcelead, Inc. Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Spinoff	Apr 1, 2019

View all Funding Rounds

Axcelead, Inc. Investors

Notable investors and investment history

Axcelead, Inc. investors
Investor	Rounds
WHIZ Partners, Inc.	Spinoff

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Apr 1, 2019
Led by WHIZ Partners, Inc. with participation from Takeda.

View all signals

Axcelead, Inc. Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Axcelead, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Axcelead, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersTokyo

Year Founded2017

Last FundingApr 1, 2019

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.